{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:18:10Z","timestamp":1790230690316,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2009,8,1]],"date-time":"2009-08-01T00:00:00Z","timestamp":1249084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2009,8]]},"DOI":"10.1016\/j.jns.2009.02.343","type":"journal-article","created":{"date-parts":[[2009,3,11]],"date-time":"2009-03-11T04:37:59Z","timestamp":1236746279000},"page":"109-115","source":"Crossref","is-referenced-by-count":65,"title":["CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia"],"prefix":"10.1016","volume":"283","author":[{"given":"Alessandro","family":"Stefani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Sancesario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Pierantozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Galati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atticus H.","family":"Hainsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Diomedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2009.02.343_bib1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.STR.14.3.399","article-title":"Diagnostic evaluation of degenerative and vascular dementia","volume":"14","author":"Loeb","year":"1983","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2009.02.343_bib2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/archneur.1975.00490510088009","article-title":"Cerebral blood flow in dementia","volume":"32","author":"Hachinski","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/archneur.1996.00550010045015","article-title":"Incorrect diagnosis of Alzheimer's disease. A clinicopathologic study","volume":"53","author":"Klatka","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00002093-199601040-00002","article-title":"Accuracy of clinical diagnosis of Alzheimer disease and clinical features of patients with non-Alzheimer disease neuropathology","volume":"10","author":"Rasmusson","year":"1996","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jns.2009.02.343_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1177\/089198879300600409","article-title":"Alzheimer's disease: the problem of incorrect clinical diagnosis","volume":"6","author":"McDaniel","year":"1993","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/0166-2236(89)90055-6","article-title":"Molecular genetic approaches to Alzheimer's disease","volume":"12","author":"Tanzi","year":"1989","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.jns.2009.02.343_bib7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/360672a0","article-title":"Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production","volume":"360","author":"Citron","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.jns.2009.02.343_bib8","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","article-title":"Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE","volume":"286","author":"Vassar","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jns.2009.02.343_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/990114","article-title":"Purification and cloning of amyloid precursor protein beta-secretase from human brain","volume":"402","author":"Sinha","year":"1999","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.jns.2009.02.343_bib10","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ana.410330506","article-title":"Dementia in Parkinson's disease: biochemical evidence for cortical involvement using the immunodetection of abnormal Tau proteins","volume":"33","author":"Vermersch","year":"1993","journal-title":"Ann Neurol."},{"key":"10.1016\/j.jns.2009.02.343_bib11","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1212\/WNL.48.3.632","article-title":"Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease","volume":"48","author":"Galasko","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.02.343_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-510X(98)00122-1","article-title":"Combination assay for CSF tau, A beta 1\u201340 and A beta 1\u201342(43) in CSF is a biological marker of AD and may be useful to biochemically monitor subjects under treatment","volume":"158","author":"Shoji","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2009.02.343_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-3-7091-6467-9_20","article-title":"Combination of the different biological markers for increasing specificity of in vivo Alzheimer's testing","volume":"53","author":"Blennow","year":"1998","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.jns.2009.02.343_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/MN:24:1-3:087","article-title":"CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease","volume":"24","author":"Blennow","year":"2001","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jns.2009.02.343_bib15","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/archneur.55.7.937","article-title":"High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype","volume":"55","author":"Galasko","year":"1998","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib16","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1001\/jama.289.16.2094","article-title":"Decreased beta-amyloid1\u201342 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease","volume":"289","author":"Sunderland","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jns.2009.02.343_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1385\/MN:24:1-3:087","article-title":"CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease","volume":"24","author":"Blennow","year":"2001","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.jns.2009.02.343_bib18","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ana.1054","article-title":"Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease","volume":"50","author":"Itoh","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0361-9230(03)00087-X","article-title":"Advances in the development of biomarkers for Alzheimer's disease: from CSF total tau and Abeta(1\u201342) proteins to phosphorylated tau protein","volume":"61","author":"Hampel","year":"2003","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.jns.2009.02.343_bib20","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1159\/000113417","article-title":"Early discriminatory diagnosis of dementia with Lewy bodies. The emerging role of CSF and imaging biomarkers","volume":"25","author":"Aarsland","year":"2008","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jns.2009.02.343_bib21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archneur.56.6.673","article-title":"Cerebrospinal fluid beta-amyloid(1\u201342) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease","volume":"56","author":"Andreasen","year":"1999","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ana.410440108","article-title":"Longitudinal study of cerebrospinal fluid levels of tau, A beta1\u201340, and A beta1\u201342(43) in Alzheimer's disease: a study in Japan","volume":"44","author":"Kanai","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib23","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0022-510X(98)00122-1","article-title":"Combination assay of CSF tau, A beta 1\u201340 and A beta 1\u201342(43) as a biochemical marker of Alzheimer's disease","volume":"158","author":"Shoji","year":"1998","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2009.02.343_bib24","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/01.wnl.0000295996.54210.69","article-title":"Disease-modifying therapies for Alzheimer disease: challenges to early intervention","volume":"69","author":"Cummings","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.02.343_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib26","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/01.wnl.0000271375.37131.04","article-title":"Longitudinal changes of CSF biomarkers in memory clinic patients","volume":"69","author":"Bouwman","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.02.343_bib27","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00702-003-0017-7","article-title":"CSF-tau, CSF-Abeta1\u201342, ApoE-genotype and clinical parameters in the diagnosis of Alzheimer's disease: combination of CSF-tau and MMSE yields highest sensitivity and specificity","volume":"10","author":"Ganzer","year":"2003","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jns.2009.02.343_bib28","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1212\/01.WNL.0000128088.08695.05","article-title":"APOE epsilon4 allele is associated with reduced cerebrospinal fluid levels of Abeta42","volume":"62","author":"Prince","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.02.343_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0197-4580(01)00272-X","article-title":"Association of CSF apolipoprotein E, Abeta42 and cognition in Alzheimer's disease","volume":"23","author":"Riemenschneider","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.jns.2009.02.343_bib30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1212\/WNL.59.4.627","article-title":"CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects","volume":"59","author":"Buerger","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.02.343_bib31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jns.2006.09.014","article-title":"CSF markers in Alzheimer disease patients are not related to the different degree of cognitive impairment","volume":"251","author":"Stefani","year":"2006","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2009.02.343_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1017\/S1041610203009499","article-title":"Toward an early diagnosis and treatment of Alzheimer's disease","volume":"15","author":"Nordberg","year":"2003","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jns.2009.02.343_bib33","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1093\/brain\/awm238","article-title":"Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease","volume":"130","author":"Pike","year":"2007","journal-title":"Brain."},{"key":"10.1016\/j.jns.2009.02.343_bib34","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1212\/01.wnl.0000261919.22630.ea","article-title":"Imaging beta-amyloid burden in aging and dementia","volume":"68","author":"Rowe","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.02.343_bib35","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","author":"Schneider","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.02.343_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1179\/016164104225016254","article-title":"Alzheimer's disease is a vasocognopathy: a new term to describe its nature","volume":"26","author":"de la Torre","year":"2004","journal-title":"Neurol Res"},{"key":"10.1016\/j.jns.2009.02.343_bib37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jns.2007.01.081","article-title":"The prevention of the dementia epidemic","volume":"257","author":"Korczyn","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2009.02.343_bib38","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1161\/STROKEAHA.107.492033","article-title":"Influence of galantamine on vasomotor reactivity in Alzheimer's disease and vascular dementia due to cerebral microangiopathy","volume":"38","author":"B\u05d4r","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2009.02.343_bib39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000103642","article-title":"Cerebrovascular reactivity in degenerative and vascular dementia: a transcranial Doppler study","volume":"58","author":"Vicenzini","year":"2007","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib40","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1161\/01.STR.0000206439.62025.97","article-title":"Cerebrovascular reactivity and cognitive decline in patients with Alzheimer disease","volume":"37","author":"Silvestrini","year":"2006","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2009.02.343_bib41","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.7863\/jum.2005.24.8.1065","article-title":"Differentiation of vascular dementia and Alzheimer disease: a functional transcranial Doppler ultrasonographic study","volume":"24","author":"Asil","year":"2005","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.jns.2009.02.343_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00415-005-0689-z","article-title":"Volume cerebral blood flow reduction in pre-clinical stage of Alzheimer disease: evidence from an ultrasonographic study","volume":"252","author":"Maalikjy Akkawi","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jns.2005.05.016","article-title":"AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis","volume":"237","author":"Stefani","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2009.02.343_bib44","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA Work Group","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.02.343_bib45","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1212\/WNL.43.11.2412-a","article-title":"The Clinical Dementia Rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2009.02.343_bib46","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini Mental State\u201d: a practical method for grading the cognitive state of patients for clinicians","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psichiatr Res"},{"key":"10.1016\/j.jns.2009.02.343_bib47","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1159\/000117297","article-title":"The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration battery","volume":"36","author":"Carlesimo","year":"1996","journal-title":"Eur Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib48","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1001\/archneur.1975.00490510088009","article-title":"Cerebral blood flow in dementia","volume":"32","author":"Hachinski","year":"1975","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib49","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"A new rating scale for age-related white matter changes applicable to MRI and TC","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2009.02.343_bib50","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF00868437","article-title":"Differentiating subtotal carotid artery stenosis from occlusion by color-coded duplex sonography","volume":"241","author":"Gortler","year":"1994","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib51","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000107895","article-title":"Quantification of atheromatous stenosis in the extracranial internal carotid artery","volume":"5","author":"De Bray","year":"1995","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.jns.2009.02.343_bib52","series-title":"Neurosonology","first-page":"83","article-title":"Vertebral sonography","author":"Bartels","year":"1995"},{"key":"10.1016\/j.jns.2009.02.343_bib53","first-page":"447","article-title":"Arterial assessment by Doppler shift ultrasound","volume":"67","author":"Gosling","year":"1974","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.jns.2009.02.343_bib54","first-page":"32","article-title":"Correlations between cognitive impairment, middle cerebral artery flow velocity and cortical glucose metabolism in the early phase of Alzheimer's disease","volume":"6","author":"Franceschi","year":"1995","journal-title":"Dementia."},{"key":"10.1016\/j.jns.2009.02.343_bib55","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1161\/STROKEAHA.107.488403","article-title":"Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment","volume":"38","author":"Debette","year":"2007","journal-title":"Stroke."},{"key":"10.1016\/j.jns.2009.02.343_bib56","first-page":"122","article-title":"Transcranial Doppler: clinical and experimental uses","volume":"4","author":"Newell","year":"1992","journal-title":"Cerebrovasc Brain Metab Rev"},{"key":"10.1016\/j.jns.2009.02.343_bib57","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1440-1789.2007.00794.x","article-title":"The role of neuroimaging in mild cognitive impairment","volume":"27","author":"Matsuda","year":"2007","journal-title":"Neuropathology"},{"key":"10.1016\/j.jns.2009.02.343_bib58","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1749-6632.2002.tb04843.x","article-title":"Hemodynamic aspects of Alzheimer's disease","volume":"977","author":"Nagata","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jns.2009.02.343_bib59","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.20516","article-title":"Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion?","volume":"57","author":"de la Torre","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib60","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(04)00683-0","article-title":"A diagnostic dilemma: is \u201cAlzheimer's dementia\u201d Alzheimer's disease, vascular dementia, or both?","volume":"3","author":"de la Torre","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004010051044","article-title":"Critical threshold cerebral hypoperfusion causes Alzheimer's disease?","volume":"98","author":"de la Torre","year":"1999","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.jns.2009.02.343_bib62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00702-003-0065-z","article-title":"Core biological marker candidates of Alzheimer's disease \u2014 perspectives for diagnosis, prediction of outcome and reflection of biological activity","volume":"111","author":"Hampel","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jns.2009.02.343_bib63","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1750-3639.1996.tb00799.x","article-title":"Brain parenchymal and microvascular amyloid in Alzheimer 's disease","volume":"6","author":"Vinters","year":"1996","journal-title":"Brain Pathol"},{"key":"10.1016\/j.jns.2009.02.343_bib64","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1749-6632.1997.tb48457.x","article-title":"Brain microvascular changes in Alzheimer's disease and other dementias","volume":"826","author":"Bu\u05d9e","year":"1997","journal-title":"Ann NY Acad Sci Neuropathol"},{"key":"10.1016\/j.jns.2009.02.343_bib65","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1161\/01.STR.0000143317.70478.b3","article-title":"Atherosclerosis of cerebral arteries in Alzheimer disease","volume":"35","author":"Roher","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2009.02.343_bib66","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/5715","article-title":"SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein","volume":"2","author":"Iadecola","year":"1999","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jns.2009.02.343_bib67","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1023\/A:1025092617651","article-title":"Cerebrovascular effects of amyloid-\u03b2 peptides: mechanisms and implications for Alzheimer's dementia","volume":"23","author":"Iadecola","year":"2003","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.jns.2009.02.343_bib68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1161\/01.STR.0000054050.51530.76","article-title":"Converging pathogenic mechanisms in vascular and neurodegenerative dementia","volume":"34","author":"Iadecola","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.jns.2009.02.343_bib69","first-page":"24","article-title":"Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD","volume":"27","author":"Borroni","year":"2006","journal-title":"Aging"},{"key":"10.1016\/j.jns.2009.02.343_bib70","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s00415-005-0926-5","article-title":"Acetylcholine esterase inhibitor donepezil improves dynamic cerebrovascular regulation in Alzheimer patients","volume":"253","author":"Rosengarten","year":"2006","journal-title":"J Neurol"},{"key":"10.1016\/j.jns.2009.02.343_bib71","doi-asserted-by":"crossref","first-page":"13309","DOI":"10.1074\/jbc.M209478200","article-title":"P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease","volume":"278","author":"Parvathenani","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jns.2009.02.343_bib72","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1212\/01.wnl.0000312383.39973.88","article-title":"An aberrant protein complex in CSF as a biomarker of Alzheimer disease","volume":"70","author":"Lovell","year":"2008","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.jns.2009.02.343_bib73","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1017\/S1092852900025888","article-title":"Clinical trials of amyloid-based therapies for Alzheimer's disease","volume":"12","author":"Tariot","year":"2007","journal-title":"CNS Spectr"},{"key":"10.1016\/j.jns.2009.02.343_bib74","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1212\/01.wnl.0000313813.48505.86","article-title":"Statins, incident Alzheimer disease, change in cognitive function, and neuropathology","volume":"70","author":"Arvanitakis","year":"2008","journal-title":"Neurology"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09004201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X09004201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T11:50:19Z","timestamp":1558180219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X09004201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8]]},"references-count":74,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2009,8]]}},"alternative-id":["S0022510X09004201"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2009.02.343","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,8]]}}}